Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroblastoma breakpoint family member 11 (NBPF11) is a protein encoded by the NBPF11 gene in humans, belonging to the neuroblastoma breakpoint (NBPF) family. The NBPF family comprises multiple, highly related genes mostly located on chromosome 1, characterized by repetitive exon structures and a high degree of sequence homology. NBPF11 is predicted to reside in the cytoplasm, contains two coiled-coil regions and six Olduvai domains (conserved regions of uncertain function). Its function remains unknown, and its association with disease is based largely on genomic position and family-level implications (e.g., involvement of NBPF genes in neuroblastoma and chromosomal syndromes). There is currently no established role for NBPF11 as a drug target or clinical biomarker, nor are there known drugs or safety concerns specifically connected to this protein.
None known (no drugs targeting NBPF11 are identified)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroblastoma breakpoint family member 11 (NBPF11).